|Bid||0.0390 x 0|
|Ask||0.0400 x 0|
|Day's range||0.0390 - 0.0390|
|52-week range||0.0320 - 0.0810|
|Beta (3Y monthly)||2.74|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Every investor in MGC Pharmaceuticals Limited (ASX:MXC) should be aware of the most powerful shareholder groups...
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! In 2016 Roby Zomer was appointed CEO of MGC Pharmaceuticals Limited (ASX:MXC). First, this article will compare CE...
A look at the shareholders of MGC Pharmaceuticals Limited (ASX:MXC) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, Read More...